Abiopharma

Lilly announces plans to open Lilly Gateway Labs site in Philadelphia

Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Naïve Adults with HIV-1 Infection

European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

Theravance Biopharma to Participate in Upcoming Investor Conferences

Keros Therapeutics Announces Preliminary Results of Tender Offer

Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc

Smith+Nephew PLC Notification

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735

Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical